Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 3 (of 3 Records) |
Query Trace: Coronary Artery Disease and CES1[original query] |
---|
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. European heart journal. Cardiovascular pharmacotherapy 2019 Sep . Lewis Joshua P, Backman Joshua D, Reny Jean-Luc, Bergmeijer Thomas O, Mitchell Braxton D, Ritchie Marylyn D, Déry Jean-Pierre, Pakyz Ruth E, Gong Li, Ryan Kathleen, Kim Eun-Young, Aradi Daniel, Fernandez-Cadenas Israel, Lee Ming Ta Michael, Whaley Ryan M, Montaner Joan, Gensini Gian Franco, Cleator John H, Chang Kiyuk, Holmvang Lene, Hochholzer Willibald, Roden Dan M, Winter Stefan, Altman Russ B, Alexopoulos Dimitrios, Kim Ho-Sook, Gawaz Meinrad, Bliden Kevin P, Valgimigli Marco, Marcucci Rossella, Campo Gianluca, Schaeffeler Elke, Dridi Nadia P, Wen Ming-Shien, Shin Jae Gook, Fontana Pierre, Giusti Betti, Geisler Tobias, Kubo Michiaki, Trenk Dietmar, Siller-Matula Jolanta M, Ten Berg Jurriën M, Gurbel Paul A, Schwab Matthias, Klein Teri E, Shuldiner Alan R, |
Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in pharmacology 2021 2 11 593982. Xu Ru-Jun, Kong Wei-Min, An Xiao-Fei, Zou Jian-Jun, Liu Li, Liu Xiao-Do |
Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamics. Clinical and translational science 2024 11 17 (11): e70079. Joshua P Lewis, Kathleen A Ryan, Elizabeth A Streeten, Hilary B Whitlatch, Melanie Daue, Keith Tanner, James A Perry, Jeffrey R O'Connell, Alan R Shuldiner, Braxton D Mitche |
- Page last reviewed:Feb 1, 2024
- Content source: